Suraj Kalia
Stock Analyst at Oppenheimer
(3.62)
# 843
Out of 4,984 analysts
82
Total ratings
44.93%
Success rate
9.47%
Average return
Main Sectors:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Upgrades: Outperform | $60 | $39.57 | +51.63% | 2 | Sep 2, 2025 | |
| PLSE Pulse Biosciences | Initiates: Outperform | $22 | $16.64 | +32.21% | 1 | Jul 7, 2025 | |
| TMDX TransMedics Group | Maintains: Outperform | $130 → $150 | $119.15 | +25.89% | 11 | Jun 17, 2025 | |
| ATRC AtriCure | Maintains: Outperform | $36 → $45 | $35.96 | +25.14% | 7 | Feb 13, 2025 | |
| VREX Varex Imaging | Maintains: Outperform | $30 → $23 | $11.63 | +97.76% | 6 | Feb 7, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $105 → $120 | $174.40 | -31.19% | 5 | Jan 8, 2025 | |
| AORT Artivion | Maintains: Outperform | $30 → $32 | $39.56 | -19.11% | 3 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Reiterates: Outperform | $90 → $93 | $92.45 | +0.59% | 2 | Nov 1, 2024 | |
| ABT Abbott Laboratories | Initiates: Outperform | $130 | $132.76 | -2.08% | 1 | Oct 8, 2024 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $10 | $4.73 | +111.42% | 1 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 | $75.09 | +19.86% | 5 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $13 | $4.65 | +179.57% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $103.07 | +30.98% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $272.60 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $13.80 | +117.39% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $320 → $200 | $2.42 | +8,164.46% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $77.48 | +25.19% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $25.98 | +7.78% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $1.63 | +176.07% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $1.57 | +919.11% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $434.50 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $660 | $2.33 | +28,226.18% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $80.80 | - | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $3.92 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $23.87 | +318.94% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $76.55 | - | 5 | Sep 12, 2018 |
PROCEPT BioRobotics
Sep 2, 2025
Upgrades: Outperform
Price Target: $60
Current: $39.57
Upside: +51.63%
Pulse Biosciences
Jul 7, 2025
Initiates: Outperform
Price Target: $22
Current: $16.64
Upside: +32.21%
TransMedics Group
Jun 17, 2025
Maintains: Outperform
Price Target: $130 → $150
Current: $119.15
Upside: +25.89%
AtriCure
Feb 13, 2025
Maintains: Outperform
Price Target: $36 → $45
Current: $35.96
Upside: +25.14%
Varex Imaging
Feb 7, 2025
Maintains: Outperform
Price Target: $30 → $23
Current: $11.63
Upside: +97.76%
iRhythm Technologies
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $174.40
Upside: -31.19%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $39.56
Upside: -19.11%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $92.45
Upside: +0.59%
Abbott Laboratories
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $132.76
Upside: -2.08%
TriSalus Life Sciences
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $4.73
Upside: +111.42%
Sep 12, 2024
Maintains: Outperform
Price Target: $90
Current: $75.09
Upside: +19.86%
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $4.65
Upside: +179.57%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $103.07
Upside: +30.98%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $272.60
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $13.80
Upside: +117.39%
Jun 23, 2023
Maintains: Outperform
Price Target: $320 → $200
Current: $2.42
Upside: +8,164.46%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $77.48
Upside: +25.19%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $25.98
Upside: +7.78%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $1.63
Upside: +176.07%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $1.57
Upside: +919.11%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $434.50
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $660
Current: $2.33
Upside: +28,226.18%
Nov 3, 2020
Upgrades: Perform
Price Target: n/a
Current: $80.80
Upside: -
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $3.92
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $23.87
Upside: +318.94%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $76.55
Upside: -